Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biogen
Biotech
Biogen boosts C-suite with BMS vet—Chutes & Ladders
Biogen boosts C-suite with BMS vet. Former Seagen CEO heads up newly emerged Ottimo Pharma. Co-founding MacroGenics CEO makes exit.
Darren Incorvaia
,
Zoey Becker
Nov 1, 2024 8:30am
Biogen buys in to molecular glues with deal worth up to $1.45B
Oct 30, 2024 10:50am
Biogen cans SAGE-324 collaboration after essential tremor fail
Sep 26, 2024 9:00am
Biogen, UCB report phase 3 lupus win after failing earlier trial
Sep 24, 2024 6:00am
Biogen CEO said no risky deals in 2023. Now he’s ready to be bold
Aug 1, 2024 10:34am
Biogen walks away from Denali Alzheimer's collab
Aug 1, 2024 10:27am